Efficacy of PosBion® Postbiotic Supplementation in Adults With Irritable Bowel Syndrome | MicrobiomeTrials← Back to trialsNCT07699926
Efficacy of PosBion® Postbiotic Supplementation in Adults With Irritable Bowel Syndrome
CompletedNAINTERVENTIONAL
Trial Details
Start: 2026-01-01Est. Completion: 2026-05-31
Enrollment target: 55 participants Locations- UCSI University, Cheras, Kuala Lumpur, Malaysia
Other microbiome trials you might be interested in
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), characterized by the Rome IV criteria, is a functional bowel disorder combining abdomina…
Lyon, FranceEst. completion Oct 10, 2028
Intestinal Disease
The gut microbiota plays a crucial role in human health, influencing metabolism, immunity, and pathogen resistance. Rese…
Rome, ItalyEst. completion Mar 10, 2027
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that substantially affects quality of li…
Istanbul, Turkey (Türkiye)Completed Nov 25, 2021